CTRI/2012/06/002741
Completed
Phase 2
Phase II study of Interim PET-CT scan-guided response adapted therapy in Hodgkinâ??s Lymphoma
Cancer Institute0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Advanced Hodgkins Lymphoma (Stage IIb, III, IV)Health Condition 2: C819- Hodgkin lymphoma, unspecifiedHealth Condition 3: C819- Hodgkin lymphoma, unspecified
- Sponsor
- Cancer Institute
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed patients of Advanced Hodgkins lymphoma\- stages IIB, III and IV
Exclusion Criteria
- •Pregnancy, Lactating Mothers
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Phase II trial: PET/CT for staging advanced and localized oral and oropharyngeal cancerEUCTR2016-002360-14-DKRigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET90
Active, not recruiting
Phase 1
uPAR PET/CT og FDG PET/CT til præoperativ stadieinddeling af patienter med nydiagnosticeret Gynækologisk Kræftgynecological cancers:Vulvar cancerendometrial cancer (uterine cancer)cervical cancerovarian cancerMedDRA version: 20.0Level: LLTClassification code 10007107Term: Cancer of ovarySystem Organ Class: 100000021045MedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000020935MedDRA version: 20.0Level: LLTClassification code 10047743Term: Vulval cancer NOSSystem Organ Class: 100000021101MedDRA version: 20.0Level: LLTClassification code 10007063Term: Cancer of endometriumSystem Organ Class: 100000021008MedDRA version: 20.0Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000020977Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]EUCTR2016-004638-99-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET350
Recruiting
Phase 2
Phase II study of interim FDG-PET-guided response-adapted therapy in pediatric patients with Hodgkin's lymphoma (HL-14)s lymphomaHodgkin'JPRN-UMIN000019093Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)50
Active, not recruiting
Phase 2
Phase II study of interim FDG-PET-guided response-adapted therapy in pediatric patients with Hodgkin's lymphoma (HL-14)JPRN-jRCTs041180174Koga Yuhki50
Not yet recruiting
Phase 1
Clearview-BC: A phase 1 Positron Emission Tomography (PET) - Computed Tomography (CT) study to evaluate the safety, biodistribution and pharmacokinetics of 89Zr-hu/mo-10D7 in patients with Bladder CancerMetastatic Bladder CancerCancer - BladderACTRN12624000824561niversity of Queensland20